Cytokinetics sec filings

Author: rlmy

August undefined, 2024

WebCytokinetics Inc. SEC filings breakout by MarketWatch. View the CYTK U.S. Securities and Exchange Commission reporting information. WebApr 4, 2024 · Pinnacle Associates Ltd. owned approximately 0.30% of Cytokinetics worth $11,556,000 as of its most recent SEC filing. Want Diversified Upside in Biotechnology? …

China Universal Asset Management Co. Ltd. Lowers Holdings in ...

WebMar 13, 2024 · Thornburg Investment Management Inc. acquired a new stake in shares of Cytokinetics, Incorporated (NASDAQ:CYTK - Get Rating) in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm acquired 74,198 shares of the biop Web11 rows · Apr 5, 2024 · Cytokinetics is a late-stage biopharmaceutical company focused on discovering, developing, and ... dark brown cowboy boots

SEC Filing Cytokinetics, Inc.

WebOn February 2, 2024, Cytokinetics also issued a press release announcing Cytokinetics entry into the Royalty Agreement. A copy of the press release is filed as Exhibit 99.1 to … WebUnder the Securities Exchange Act of 1934 (AMENDMENT NO. 1) CYTOKINETICS, INCORPORATED (Name of Issuer) COMMON STOCK, PAR VALUE $0.001 PER … WebApr 9, 2024 · Cytokinetics Trading Up 0.7 %. Cytokinetics stock opened at $36.42 on Friday. The business’s 50 day simple moving average is $39.79 and its 200 day simple moving average is $42.22. dark brown countertops

Logos Global Management LP Sells 50,000 Shares of Cytokinetics ...

Cytokinetics To Participate In The 22nd Annual Needham Virtual ...

WebItem 1.01 Entry into a Material Definitive Agreement. On February 1, 2024, Cytokinetics, Incorporated ("Cytokinetics") entered into a Royalty Purchase Agreement (the "Royalty Agreement") with RPI Finance Trust ("RPI"), an entity related to Royalty Pharma. WebApr 13, 2024 · China Universal Asset Management Co. Ltd. trimmed its holdings in Cytokinetics, Incorporated (NASDAQ:CYTK – Get Rating) by 96.6% during the 4th … bischoff camille masevauxWebMar 27, 2024 · empowering muscle empowering lives. Cytokinetics is committed to our mission of developing potential medicines that may improve the healthspan of people living with cardiovascular and … bischoff blood type o chart

"WebPipeline - Cytokinetics A pipeline powered by passion pipeline Research Pre-Clinical Phase 1 Phase 2 Phase 3 CARDIAC MUSCLE Omecamtiv Mecarbil (Heart Failure) Aficamten (oHCM) Aficamten (nHCM) CK-136 (Heart Failure, other) CK-586 SKELETAL MUSCLE Reldesemtiv (ALS) Additional Skeletal Muscle Activators Other Muscle Biology … " - Cytokinetics sec filings

Cytokinetics sec filings

Cytokinetics Inc (CYTK) SEC Filing 8-K Material Event for the …

WebJan 8, 2024 · According to the 10-Q SEC Filing, Cytokinetics had cash, cash equivalents and investments of $668.9 million as of September 30, 2024. A big reason for the cash on hand was because of an offering ... WebCytokinetics is a late-stage biopharmaceutical company focused on discovering, developing, and commercializing muscle activators and inhibitors. Our Vision. ... SEC Filings. Annual Report and Proxy. Analyst Coverage. Investor FAQ. IR/Media Contacts. Corporate Governance. Information Request. Email Alerts.

Did you know?

WebApr 9, 2024 · Posted by Defense World Staff on Apr 9th, 2024 Inspire Investing LLC increased its stake in shares of Cytokinetics, Incorporated ( NASDAQ:CYTK – Get Rating) by 19.1% during the 4th quarter,... WebFeb 22, 2024 · Cytokinetics is a late-stage biopharmaceutical company focused on discovering, developing, and commercializing muscle activators and inhibitors. …

WebNov 4, 2024 · SEC Filings Cytokinetics Inc (CYTK) 10-Q Quarterly Report Fri Nov 04 2024 SEC Filings CYTK Valuations Intrinsic Value Financial Stability Financial Ratios Insider …

WebJan 9, 2024 · Filings & Forms All companies, foreign and domestic, are required to file registration statements, periodic reports, and other forms electronically through EDGAR. Anyone can access and download this information for free. Here you'll find links to a complete list of filings available through EDGAR and instructions for searching the … WebApr 12, 2024 · Oregon Public Employees Retirement Fund lifted its position in shares of Cytokinetics, Incorporated (NASDAQ:CYTK – Get Rating) by 1.0% in the 4th quarter, …

WebApr 12, 2024 · The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. In related news, CEO Robert I. Blum sold 12,500 shares of the stock in a transaction that ...

WebFind the latest Cytokinetics, Incorporated (CYTK) stock quote, history, news and other vital information to help you with your stock trading and investing. ... SEC Filings. GlobeNewswire ... bischoff calwWebCytokinetics is a late-stage biopharmaceutical company focused on discovering, developing, and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential treatments for people with debilitating diseases in which muscle performance is compromised and/or declining. bischoff bookWebFeb 25, 2024 · Cytokinetics Inc (CYTK) SEC Filing 10-K Annual Report for the fiscal year ending Friday, December 31, 2024 Earnings Press Release 10-K Annual Report 10-K … bischoff bottle carrierWebJul 1, 2024 · Cytokinetics is a late-stage biopharmaceutical company focused on discovering, developing and commercializing first-in-class muscle activators and next-in … bischoff cabinetmakingWebFind the latest SEC Filings data for Cytokinetics, Incorporated Common Stock (CYTK) at Nasdaq.com. Cytokinetics, Incorporated Common Stock (CYTK) SEC Filings … bischoff buckley collinsWebApr 10, 2024 · Cytokinetics To Participate In The 22nd Annual Needham Virtual Healthcare Conference. SOUTH SAN FRANCISCO, Calif., April 10, 2024 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK ... bischoff carolineWebMar 3, 2024 · Fri., March 3, 2024 MarketBeat Logos Global Management LP cut its holdings in shares of Cytokinetics, Incorporated ( NASDAQ:CYTK - Get Rating) by 2.9% during the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). dark brown cowboy boots men